Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) was the recipient of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 50,500 shares, a decrease of 51.1% from the February 28th total of 103,300 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 609,700 shares, the days-to-cover ratio is currently 0.1 days.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on RBGLY. HSBC upgraded Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Barclays cut shares of Reckitt Benckiser Group from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, February 4th. Royal Bank of Canada restated an “outperform” rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th. Finally, Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating, two have given a buy rating and three have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Reckitt Benckiser Group presently has an average rating of “Buy”.
View Our Latest Stock Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Increases Dividend
The firm also recently disclosed a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 11th will be paid a $0.2909 dividend. This is a boost from Reckitt Benckiser Group’s previous dividend of $0.19. The ex-dividend date of this dividend is Friday, April 11th.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- 5 Top Rated Dividend Stocks to Consider
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.